Dr. Alifiya Fakhri, MD



Internal Medicine   -  Missouri,  Chesterfield

 Overview

Dr. Alifiya Fakhri, MD works in Chesterfield, Missouri is a specialist in Internal Medicine. 

 Specialties

  • Internal Medicine

 State License

  • Missouri

 Education & Training

Education for Dr. Alifiya Fakhri, MD are not present.

 Awards

Awards for Dr. Alifiya Fakhri, MD are not present.

 Dr. Fakhri Reviews

Reviews for Dr. Alifiya Fakhri, MD are not present. Be the first to review this doctor!
 Add Review as registered PatientOR Add Review as Guest

 Office Locations


Primary location

 Office Address
232 South Woods Mill Road
Missouri (MO)
Chesterfield
63017
 Phone:(314) 205-6736

Accepting New Patients

  • No
* Please verify this information when scheduling an appointment.

 Map & Directions



Office Address, 232 South Woods Mill Road, Chesterfield, Missouri (MO), 63017




 Insurances Accepted (check insurance plans)

  • Amerigroup (Wellpoint)
  • Blue Cross Blue Shield
  • CHAMPVA
  • Cigna
  • Commercial Insurance Company
  • Humana
  • Medicaid
  • Medicare
  • Medicare MCR
  • Molina
  • Molina Healthcare
  • National Elevator

* Please verify this information when scheduling an appointment.

 Blog Posts

Blog Posts for Dr. Alifiya Fakhri, MD are not present.

 Patients Questions

Patients questions for Dr. Alifiya Fakhri, MD are not present.

 Affiliated Hospitals

Affiliated hospitals for Dr. Alifiya Fakhri, MD are not present.

  •  Latest reviews for Internal Medicine specialists

  • Dr. C. is a pleasant, professional caring and fun doctor. Answered all my questions on a keep it simple level and explained everything. He took his time. I will refer them when needed. What a great group!
    07 February 2024
    (6)
  • He is the best if you need help with panic attacks. He fixed up my medication and I feel better.
    31 January 2024
    (40)
  • Dr. Jungblut and staff are all professional, fun, conscientious. Been going here for a long time. My children and grandchildren now see Dr. Jungblut too.
    24 January 2024
    (7)
Close
Sign Up / Login
Connect with Sign Up / Login